Source - SMW
Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1540p (from 1700p).

Related Charts

GlaxoSmithKline (GSK)

0.00 (0.00%)
delayed 17:30PM